Blood Reviews
Volume 22, Issue 3 , Pages 141-153 , May 2008

Inherited aplastic anaemias/bone marrow failure syndromes

References 

  1. Alter BP. Inherited bone marrow failure syndromes. In:  Nathan DG,  Orkin SH,  Look AT,  Ginsburg D editor. Nathan and Oski’s Hematology of Infancy and Childhood. 6th ed.. Philadelphia, PA: WB Saunders; 2003;p. 280–365
  2. Auerbach AD, Buchwald M, Joenje H. In:  Scriver CR, et al. editor. The Metabolic and Molecular Basis Of Inherited Disease. New York: McGraw-Hill; 2001;p. 753–768
  3. Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia- clinical and molecular aspects. Br J Haematol. 2004;126:176–191
  4. Levitus M, Rooimans MA, Steltenpool J, et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood. 2004;103:2493–2503
  5. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7:249–262
  6. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002;297:606–609
  7. Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nature Genet. 2007;39:142–143
  8. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nature Rev Genet. 2007;6:735–748
  9. Smogorzewska A, Matsuoka S, Vinciguerra P, et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell. 2007;129:289–301
  10. Guardiola P, Socie G, Pasquini R, et al. Allogeneic stem cell transplantation for Fanconi anaemia. Bone Marrow Transplant. 1998;21(suppl 2):24–27
  11. Guardiola Ph, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood. 2000;95:422–429
  12. de la Fuente J, Reiss S, McCloy M, et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant. 2003;32:653–656
  13. Motwani J, Lawson SE, Darbyshire PJ. Successful HSCT using nonradiotherapy-based conditioning regimens and altenative donors in patients with Fanconi anaemia- experience in a single UK centre. Bone Marrow Transplant. 2005;36:405–410
  14. Wagner JE, Eapen M, MacMillan ML, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood. 2007;109:2256–2262
  15. Liu JM, Kim S, Read EJ, et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther. 1999;10:2337–2346
  16. Waisfisz Q, Morgan NV, Savino M, et al. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nature Genet. 1999;22:379–383
  17. Vulliamy T, Dokal I. Dyskeratosis congenita. Seminars in Hematology. 2006;43:157–166
  18. Connor JM, Gatherer D, Gray FC, et al. Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet. 1986;72:348–351
  19. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genet. 1998;19:32–38
  20. Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol. 1999;107:335–339
  21. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551–555
  22. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413:432–435
  23. Vulliamy T, Marrone A, Dokal I, et al. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 2002;359:2168–2170
  24. Yamaguchi H, Baerlocher GM, Lansdorp PM, et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood. 2003;102:916–918
  25. Keith WN, Vulliamy T, Zhao J, Ar C, Erzik C, Bisland A, et al. A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with paroxysmal nocturnal haemoglobinuria. BMC Blood Disorders. 2004;4:3–11
  26. Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for reverse transcriptase, in aplastic anemia. N Eng J Med. 2005;352:1413–1424
  27. Vulliamy T, Walne A, Baskaradas A, et al. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis. 2005;34:257–263
  28. Armanios M, Chen JL, Chang YPC, et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA. 2005;102:15960–15964
  29. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007;356(13):1317–1326
  30. Walne AJ, Vulliamy T, Marrone A, et al. Genetic Heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet. 2007;16:1619–1629
  31. Yoon A, Peng G, Brandenburger Y, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science. 2006;312(5775):902–906
  32. Ruggero D, Grisendi S, Piazza F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 2003;299:259–262
  33. Alter BP, Gardner EH, Hall RE. Treatment of dyskeratosis congenita with granulocyte macrophage colony-stimulating factor and erythropoietin. Br J Haematol. 1997;97:309–311
  34. de la Fuente J, Dokal I. Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatric Transplantation. 2007;11:584–594
  35. Shwachman H, Diamond LK, Oski FA, Khaw KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr. 1964;65:645–663
  36. Bodian M, Sheldon W, Lightwood R. Congenital hypoplasia of the exocrine pancreas. Acta Paediatr. 1964;53:282–293
  37. Dror Y, Freedman MH. Shwachman-Diamond syndrome. Br J Haematol. 2002;118:701–713
  38. Boocock GRB, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nature Genet. 2003;33:97–101
  39. Shammas C, Menne TF, Hilcenko C, et al. Structural and mutational analysis of the SBDS protein family. Insight into the leukemia-associated Shwachman Diamond Syndrome. J Biol Chem. 2005;13:19221–19229
  40. Menne TF, Goyenechea B, Sanchez-Puig N, et al. The Shwachman-Bodian_Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nature Genet. 2007;39:486–496
  41. Cesaro S, Oneto R, Messina C, et al. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol. 2005;131:231–236
  42. Lipton JM, Atsidaftos E, Zyskind I, Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer. 2006;46:558–564
  43. Giri N, Kang E, Tisdalew JF, et al. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol. 2000;108:167–175
  44. Orfali KA, Ohene-Abuakwa Y, Ball SE. Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br J Haematol. 2004;125:243–252
  45. Draptchinskaia N, Gustavsson P, Andersson B, et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nature Genet. 1999;21:169–175
  46. Willig T-N, Dratchinskaia N, Dianzani I, et al. Mutations in Ribosomal Protein S19 and Diamond Blackfan Anemia: Wide Variations in Phenotypic Expression. Blood. 1999;94:4294–4306
  47. Gazda HT, Sieff CA. Recent insights into the pathogenesis of Diamond-Blackfan anaemia. Br J Haematol. 2006;135:149–157
  48. Gazda HT, Graowska A, Merida-Long LB, et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anaemia. Am J Hum Genet. 2006;79:1110–1118
  49. Cmejla R, Cmejlova J, Handrkova H, Petrak J, Pospisilova D. Ribosomal Protein S17 Gene (RPS17) is mutated in Diamond-Blackfan Anemia. 2007; Hum Mutat 0: 1-5.
  50. Ihara K, Ishii E, Eguchi M, et al. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci USA. 1999;96:3132–3136

PII: S0268-960X(07)00072-0

doi: 10.1016/j.blre.2007.11.003

Blood Reviews
Volume 22, Issue 3 , Pages 141-153 , May 2008

Article Tools

* Image Usage & Resolution